AARNet
AARNet is Australia’s national research and education network, a not-for-profit organisation equally owned by 38 Australian universities and CSIRO. AARNet provides essential high-speed internet and advanced network services tailored to meet the specialised needs of researchers in Australia.
Unlocking the power of Australia’s Tier 1 supercomputer
Through a national framework for trusted identity, accessing one of Australia’s Tier 1 supercomputers will become easier. The Pawsey Supercomputing Research Centre (Pawsey) is one of two Tier-1 high-performance computing facilities in Australia. Its primary function is to accelerate scientific research for the benefit of the nation. Pawsey’s service and expertise in supercomputing, data, cloud […]
Future-proofing computational proteomics
EMBL Australia and Bioplatforms Australia joined forces to host a pivotal proteomics workshop titled ‘Future-proofing Computational Proteomics’ on 24 April, featuring leading guest speakers, Dr Rolf Apweiler, Prof Marc Wilkins and Dr Richard Lipscombe. The Australian proteomics community discussed advancements in proteomics research and the pivotal role of computational approaches in shaping the future of […]
Australian health research infrastructure underpins world-first brain cancer collaboration
The NCRIS Health Group will support Australian brain cancer research through Brain Cancer Australia’s project to develop an integrated network of research platforms to improve patient outcomes, test new treatments and work toward a cure, with the announcement of a Medical Research Future Fund (MRFF) grant worth just under $6M. The project brings together clinicians, […]
Pawsey Supercomputing Research Centre (Pawsey)
Pawsey Supercomputing Research Centre, Australia’s leading Tier-1 high-performance computing facility, is advancing research and innovation by providing cutting-edge supercomputing, data and visualisation infrastructure and expertise. From accelerating breakthroughs in medicine and climate science to unlocking the mysteries of the universe, Pawsey is at the forefront of driving discovery and advancing knowledge.
Phenomics Australia (PA)
Phenomics Australia provides a national capability to explore the human genome and the genetic basis of health and disease. Our openly accessible service delivery centres span twenty locations across Australia. Through these, we offer specialised infrastructure, research services and technical expertise dedicated to advancing our fundamental understanding of health and disease and enabling next-generation innovations in healthcare and therapeutic development to benefit all Australians.
Australian National Fabrication Facility (ANFF)
ANFF owns and provides access to micro and nanofabrication capabilities for Australia’s researchers and industry. We can assist in both the development of new products and improvements to current production methods. Each Node provides expertise in a specific area, including advanced materials, nanoelectronics & photonics and nano-bio applications. The ANFF commitment to providing a world-class, open-access user facility is underpinned by the sharing of best practice in service provision across the network.
Protein discovery for better bowel cancer treatments
Bowel cancer claims more than 100 lives in Australia every week. Thankfully, researchers at the Australian National University (ANU) have discovered that an immune protein can slow the division of bowel cancer cells. This is a promising target for both early detection tests and bowel cancer treatments. DR ABHIMANU PANDEY SAYS AN IMMUNE SYSTEM PROTEIN […]
Strengthening our European connections to EMBL and beyond
On a recent visit to EMBL Heidelberg, Ian Smith, Chair of the EMBL Australia Council, spoke about the synergies between EMBL and EMBL Australia, opportunities for collaboration and ideas for exciting future programs. Ian Smith, Chair of the EMBL Australia Council, chatted to EMBL about the synergies between the organisations, opportunities for collaboration, and ideas […]
Vaccine patch delivers protection from dengue in mice
Dengue is the most significant mosquito-borne viral disease in the world. With an estimated 390 million cases annually, it results in approximately US$6.9 billion in economic losses. Now Dr David Muller and the vaccine team at the University of Queensland (UQ) have developed a promising dengue vaccine candidate that provides strong immunity in mice when […]
Biobanks: the Australian Phenome Bank
The Australian Phenome Bank: a national biobank and database aiding the discovery of genetic disease causes and advancing Personalised Medicine. Phenomics Australia’s Biobanking service provides a database and cryobank of mouse sperm and embryos essential for discovering and distributing disease models in Australia. The challenge: Ensuring the ongoing availability of mouse strains preserving the investment made in […]
CRISPR/Cas as diagnostics tools
Phenomics Australia NCRIS expertise is used in providing knowledge to look into the commercial and translational potential of CRISPR technology. Phenomics Australia’s long-term support of the In vivo Genome Engineering and Disease Modelling nodes over the years has allowed researchers at the Melbourne Advanced Genome Editing Center (MAGEC) to have a solid understanding of CRISPR/Cas […]
When food kills
Infrastructure and expertise supported by Phenomics Australia and Therapeutic Innovation Australia (TIA)are used in fighting food poisoning toxins. Prof Si Ming Man (right) and Dr Anukriti Mathur (left). Image Lannon Harley/ANU The challenge: Food poisoning is estimated to affect more than 4 million Australians every year – costing the economy $1.25 billion, and in some […]
WearOptimo create real-time, Microwearable health sensors
WearOptimo have used Microscopy Australia’s facilities to develop a world-first, wearable, real-time health sensor, which is now in clinical trials. WearOptimo aims to provide affordable, wearable technology to revolutionise monitoring of biomarkers, which act as an early warning sign of disease. Initially, their sticker like device will provide real time monitoring of hydration and of heart […]
How Australia’s national research infrastructure is responding to COVID-19
Australia’s National Research Infrastructure (NRI) swiftly redeployed to support national and international COVID-19 research. Some examples are listed below. Australian Centre for Disease Preparedness (ACDP), Bioplatforms Australia (BPA), Microscopy Australia and Therapautic Innovation Australia (TIA) were involved in the University of Queensland vaccine program. Australian Plant Phenomics Facility (APPF) is supporting research into plant-based vaccines. Astronomy Australia […]
New Era in X-Ray Imaging
Next generation X-ray technology, developed and manufactured in Adelaide, is solving global health, defence and security challenges by making X-ray machines significantly lighter and more portable. In-depth imaging is now available on the move thanks to Adelaide-based medical device manufacturer, Micro-X, which has commercialised a new way of producing x-rays. The ASX-listed company is harnessing […]
